Evaluation of Biomarkers for HER3-targeted Therapies in Cancer.

EBioMedicine

Translational Research Unit, Dr Rosell Oncology Institute, Quirón Dexeus University Hospital, 08028 Barcelona, Spain ; Cancer Biology and Precision Medicine Program, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Ctra Canyet s/n, 08916 Badalona, Barcelona, Spain ; Fundación Molecular Oncology Research (MORe), Sabino Arana 5-19, 08028 Barcelona, Spain.

Published: March 2015

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484505	PMC
http://dx.doi.org/10.1016/j.ebiom.2015.02.010	DOI Listing

Publication Analysis

Top Keywords

evaluation biomarkers

biomarkers her3-targeted

her3-targeted therapies

therapies cancer

evaluation

her3-targeted

therapies

cancer

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!